Emerging and Re-Emerging Infectious Diseases , An Issue of Infectious Disease Clinics of North America, 1st Edition
著者 :
Edited by Alimuddin Zumla, BSc.MBChB.MSc.PhD.FRCP(Lond).FRCP(Edin).FRCPath(UK) and David S.C. Hui, MD (USNW), FRACP, FRCP
In consultation with Consulting Editor, Dr. Helen Boucher, Drs. Zumla and Hui have assembled an excellent clinical overview of the current priorities in treating emerging and re-emerging infections. A number of landmark events have occurred in the ar
...view more
In consultation with Consulting Editor, Dr. Helen Boucher, Drs. Zumla and Hui have assembled an excellent clinical overview of the current priorities in treating emerging and re-emerging infections. A number of landmark events have occurred in the area of epidemic infections. The frequency and diversity of serious and drug/antibiotic-resistant infections are increasing. New and re-emerging infectious disease outbreaks continue to cause much human suffering and loss of life worldwide. Current priority infectious diseases concerns that threaten global health security are covered in this issue: Cholera; Typhoid and antibiotic-resistant strains; multi—drug-resistant Tuberculosis; Invasive Meningococcal disease; Invasive Pneumococcal disease; antibiotic-resistant bacterial, viral, and protozoal infections; diphtheria; pandemic influenza; MERS; SARS; Measles; viral haemorrhagic fevers; wild-type Polio virus; Zika; antibiotic-resistant sexually transmitted diseases; drug-resistant Malaria; ARV-resistant HIV; and fungal infections. This issue’s clinical review articles, written by authoritative and renowned experts in the area would, have broad appeal, from general internists to respiratory specialists. It should also prove interesting to infectious diseases specialists, health practitioners in the tropics, pulmonologists, internal medicine fellows, family physicians, and health-care policy makers in the west and developing countries. Medical students, postgraduates, and research fellows (both undergraduates and postgraduates) will also find this issue useful and to be a updated reference in the field of respiratory medicine, tropical medicine, and infectious diseases.
In consultation with Consulting Editor, Dr. Helen Boucher, Drs. Zumla and Hui have assembled an excellent clinical overview of the current priorities in treating emerging and re-emerging infections. A number of landmark events have occurred in the area of epidemic infections. The frequency and diversity of serious and drug/antibiotic-resistant infections are increasing. New and re-emerging infectious disease outbreaks continue to cause much human suffering and loss of life worldwide. Current priority infectious diseases concerns that threaten global health security are covered in this issue: Cholera; Typhoid and antibiotic-resistant strains; multi—drug-resistant Tuberculosis; Invasive Meningococcal disease; Invasive Pneumococcal disease; antibiotic-resistant bacterial, viral, and protozoal infections; diphtheria; pandemic influenza; MERS; SARS; Measles; viral haemorrhagic fevers; wild-type Polio virus; Zika; antibiotic-resistant sexually transmitted diseases; drug-resistant Malaria; ARV-resistant HIV; and fungal infections. This issue’s clinical review articles, written by authoritative and renowned experts in the area would, have broad appeal, from general internists to respiratory specialists. It should also prove interesting to infectious diseases specialists, health practitioners in the tropics, pulmonologists, internal medicine fellows, family physicians, and health-care policy makers in the west and developing countries. Medical students, postgraduates, and research fellows (both undergraduates and postgraduates) will also find this issue useful and to be a updated reference in the field of respiratory medicine, tropical medicine, and infectious diseases.
著者情報
Edited by Alimuddin Zumla, BSc.MBChB.MSc.PhD.FRCP(Lond).FRCP(Edin).FRCPath(UK), Professor of Infectious Disease and International Health, University College London, Royal Free and University College, London Medical School; Director, Centre for Infectious Diseases and International Health, Windeyer Institute of Medical Sciences, University College London, London, UK; Honorary Consultant in Infectious Diseases, University College London Hospitals NHS Trust, London, UK; Honorary consultant physician, St. Luke’s Hospital for the Clergy, London; Honorary Professor, Liverpool S and David S.C. Hui, MD (USNW), FRACP, FRCP
Edited by Alimuddin Zumla, BSc.MBChB.MSc.PhD.FRCP(Lond).FRCP(Edin).FRCPath(UK), Professor of Infectious Disease and International Health, University College London, Royal Free and University College, London Medical School; Director, Centre for Infectious Diseases and International Health, Windeyer Institute of Medical Sciences, University College London, London, UK; Honorary Consultant in Infectious Diseases, University College London Hospitals NHS Trust, London, UK; Honorary consultant physician, St. Luke’s Hospital for the Clergy, London; Honorary Professor, Liverpool S and David S.C. Hui, MD (USNW), FRACP, FRCP
eBooks : Built for busy schedules & tailored for your goals.
Affordable knowledge, built for you
Get the resources you need-often at a lower cost than print. Quality content designed to support your goals, without stretching your budget.
Seamless access wherever you are
Open your eBook on your laptop, tablet, or phone - online or offline. Learning fits into your life, no matter where you go.
Always in sync
Start reading on one device and pick up right where you left off on another. Your progress and notes stay with you, every step of the way.
Tools the make learning stick
Highlight key points, take notes, create flashcards, or listen to your eBook read aloud. Interactive features help you deepen your knowledge, your way.
Your eBook is ready whenever you are!
1. Check your email for your access code.
2. Sign into or create your VitalSource account and redeem your code.
The access code for your new eBook will be sent in your order confirmation email. Your code can also be accessed in your My Account section on the Elsevier webshop.
If you do not receive your code within a few minutes, please check your spam folder.
Step-by-step guidance on how to download Bookshelf and also redeem your code can be found here.
The access code for your new eBook does not expire. However, we always suggest redeeming immediately after purchase to start experiencing the benefits of and insights from your purchase. Important to note - the code provided is a single use code and only valid for the edition you purchase. It does not provide access to past nor future editions of the title.
You will have unlimited access to your eBook on the device to which it was downloaded.
Discover the various learning features that our eBooks offer on the Bookshelf® Reader! For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information on the learning functions can be found on the Vitalsource page.
Quality is our top priority. That's why we collaborate with the leading eBook reader provider VitalSource. VitalSource has its own eBook reader Bookshelf®, which you can easily download. This reader is very user-friendly and offers more features than other standard readers. For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information can be found on the Vitalsource page.
Elsevier offers its eBooks in ePub format, as we believe this format is best suited to display our content ideally on as many devices as possible.
You can return your eBook within 13 days of purchase. eBooks that have been partially printed or flipped through more than 15% are excluded from returns.
https://shop.elsevier.jp/emerging-and-re-emerging-infectious-diseases-an-issue-of-infectious-disease-clinics-of-north-america-9780323708456.html296570Emerging and Re-Emerging Infectious Diseases , An Issue of Infectious Disease Clinics of North Americahttps://secure-ecsd.elsevier.com/covers/80/Tango2/large/9780323708456.jpg1779117791JPYInStock/Medicine & Surgery/Infectious Disease/Clinics/Medicine/Infectious Disease/Clinics/Clinics/Medicine/Infectious Disease/Product Format/Clinics/Product Format/Clinics/Product Format/Clinics4335146438872550546235054666525504152598605936812593682659368311418269243350884886536505455351451205259833593680959368235936828In consultation with Consulting Editor, Dr. Helen Boucher, Drs. Zumla and Hui have assembled an excellent clinical overview of the current priorities in treating emerging and re-emerging infections. A number of landmark events have occurred in the area of epidemic infections. The frequency and diversity of serious and drug/antibiotic-resistant infections are increasing. New and re-emerging infectious disease outbreaks continue to cause much human suffering and loss of life worldwide. Current priority infectious diseases concerns that threaten global health security are covered in this issue: Cholera; Typhoid and antibiotic-resistant strains; multi—drug-resistant Tuberculosis; Invasive Meningococcal disease; Invasive Pneumococcal disease; antibiotic-resistant bacterial, viral, and protozoal infections; diphtheria; pandemic influenza; MERS; SARS; Measles; viral haemorrhagic fevers; wild-type Polio virus; Zika; antibiotic-resistant sexually transmitted diseases; drug-resistant Malaria; ARV-resistant HIV; and fungal infections. This issue’s clinical review articles, written by authoritative and renowned experts in the area would, have broad appeal, from general internists to respiratory specialists. It should also prove interesting to infectious diseases specialists, health practitioners in the tropics, pulmonologists, internal medicine fellows, family physicians, and health-care policy makers in the west and developing countries. Medical students, postgraduates, and research fellows (both undergraduates and postgraduates) will also find this issue useful and to be a updated reference in the field of respiratory medicine, tropical medicine, and infectious diseases. In consultation with Consulting Editor, Dr. Helen Boucher, Drs. Zumla and Hui have assembled an excellent clinical overview of the current priorities in treating emerging and re-emerging infections. A number of landmark events have occurred in the area of epidemic infections. The frequency and diversity of serious and drug/antibiotic-resistant infections are increasing. New and re-emerging infectious disease outbreaks continue to cause much human suffering and loss of life worldwide. Current priority infectious diseases concerns that threaten global health security are covered in this issue: Cholera; Typhoid and antibiotic-resistant strains; multi—drug-resistant Tuberculosis; Invasive Meningococcal disease; Invasive Pneumococcal disease; antibiotic-resistant bacterial, viral, and protozoal infections; diphtheria; pandemic influenza; MERS; SARS; Measles; viral haemorrhagic fevers; wild-type Polio virus; Zika; antibiotic-resistant sexually transmitted diseases; drug-resistant Malaria; ARV-resistant HIV; and fungal infections. This issue’s clinical review articles, written by authoritative and renowned experts in the area would, have broad appeal, from general internists to respiratory specialists. It should also prove interesting to infectious diseases specialists, health practitioners in the tropics, pulmonologists, internal medicine fellows, family physicians, and health-care policy makers in the west and developing countries. Medical students, postgraduates, and research fellows (both undergraduates and postgraduates) will also find this issue useful and to be a updated reference in the field of respiratory medicine, tropical medicine, and infectious diseases.00add-to-cart97803237084562019専門医Edited by Alimuddin Zumla, BSc.MBChB.MSc.PhD.FRCP(Lond).FRCP(Edin).FRCPath(UK) and David S.C. Hui, MD (USNW), FRACP, FRCP20201Book152w x 229h (6.00" x 9.00")Elsevier02019/10/28IN STOCKEdited by <STRONG>Alimuddin Zumla</STRONG>, BSc.MBChB.MSc.PhD.FRCP(Lond).FRCP(Edin).FRCPath(UK), Professor of Infectious Disease and International Health, University College London, Royal Free and University College, London Medical School; Director, Centre for Infectious Diseases and International Health, Windeyer Institute of Medical Sciences, University College London, London, UK; Honorary Consultant in Infectious Diseases, University College London Hospitals NHS Trust, London, UK; Honorary consultant physician, St. Luke’s Hospital for the Clergy, London; Honorary Professor, Liverpool S and <STRONG>David S.C. Hui</STRONG>, MD (USNW), FRACP, FRCPClinicsClinicsThe Clinics: Internal Medicine米国いいえいいえいいえいいえいいえ選択してください選択してくださいいいえいいえ選択してください
